(Q46960869)

26 December 2017

title

Cell cycle-dependent cytotoxic and cytostatic effects of bortezomib on colon carcinoma cells. (English)

1 reference

26 December 2017

1 reference

9

Kroemer G

1 reference

26 December 2017

Coquelle A

1

1 reference

26 December 2017

Mouhamad S

2

1 reference

26 December 2017

Pequignot MO

3

1 reference

26 December 2017

Braun T

4

1 reference

26 December 2017

Carvalho G

5

1 reference

26 December 2017

Vivet S

6

1 reference

26 December 2017

Métivier D

7

1 reference

26 December 2017

Castedo M

8

1 reference

26 December 2017

publication date

1 May 2006

1 reference

26 December 2017

Cell Death & Differentiation

published in

1 reference

26 December 2017

volume

13

1 reference

26 December 2017

page(s)

873-875

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401881

exact match

0 references

cites work

The IKK NF-kappa B system: a treasure trove for drug development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401881

NF-kappa B as a therapeutic target in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401881

Pharmacological manipulation of cell death: clinical applications in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401881

The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401881

Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401881

Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401881

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401881

Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401881

Camptothecin causes cell cycle perturbations within T-lymphoblastoid cells followed by dose dependent induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401881

Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401881

Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401881

NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401881

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CDD.4401881

1 reference

26 December 2017

PubMed ID

16498456

1 reference

26 December 2017